Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ALKJAERSIG N., FLETCHER A. P., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. II. The significance, mechanism and consequences of defective fibrin polymerization. J Clin Invest. 1962 Apr;41:917–934. doi: 10.1172/JCI104547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ASTRUP T., ALBRECHTSEN O. K. Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scand J Clin Lab Invest. 1957;9(3):233–243. doi: 10.3109/00365515709079963. [DOI] [PubMed] [Google Scholar]
- ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
- ASTRUP T., RASMUSSEN J., AMERY A., POULSEN H. E. Fibrinolytic activity of cirrhotic liver. Nature. 1960 Feb 27;185:619–620. doi: 10.1038/185619a0. [DOI] [PubMed] [Google Scholar]
- BIGGS A. W., DOUGDALE M., RAINES S. L., NEFT L. G. The use of fat emulsion intravenously in the control of hemorrhage due to thrombolysin activity. South Med J. 1961 Nov;54:1252–1254. doi: 10.1097/00007611-196111000-00007. [DOI] [PubMed] [Google Scholar]
- DILLARD G. H. L., CHANUTIN A. The protease and antiprotease of plasmas of patients with cancer and other diseases. Cancer Res. 1949 Nov;9(11):665–668. [PubMed] [Google Scholar]
- FANTL P. Plasminogen activity of plasma and serum. Science. 1962 Mar 9;135(3506):787–788. doi: 10.1126/science.135.3506.787. [DOI] [PubMed] [Google Scholar]
- FINKBINER R. B., McGOVERN J. J., GOLDSTEIN R., BUNKER J. P. Coagulation defects in liver disease and response to transfusion during surgery. Am J Med. 1959 Feb;26(2):199–213. doi: 10.1016/0002-9343(59)90309-2. [DOI] [PubMed] [Google Scholar]
- FLETCHER A. P., ALKJAERSIG N., SHERRY S. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products. J Clin Invest. 1962 Apr;41:896–916. doi: 10.1172/JCI104546. [DOI] [PMC free article] [PubMed] [Google Scholar]
- GANS H., KRIVIT W. Problems in hemostasis during openheart surgery. III. Epsilon amino caproic acid as an inhibitor of plasminogen activator activity. Ann Surg. 1962 Feb;155:268–276. doi: 10.1097/00000658-196200000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- KWAAN H. C., MCFADZEAN A. J., COOK J. Plasma fibrinolytic activity in cirrhosis of the liver. Lancet. 1956 Jan 21;270(6908):132–136. doi: 10.1016/s0140-6736(56)91093-5. [DOI] [PubMed] [Google Scholar]
- LASSEN M. Heat denaturation of plasminogen in the fibrin plate method. Acta Physiol Scand. 1953 Feb 28;27(4):371–376. doi: 10.1111/j.1748-1716.1953.tb00951.x. [DOI] [PubMed] [Google Scholar]
- PENN S. R., WALKER J. H. Defective blood coagulation following pulmonary surgery. N Engl J Med. 1954 May 6;250(18):764–765. doi: 10.1056/NEJM195405062501804. [DOI] [PubMed] [Google Scholar]
- PHILLIPS L. L., SKRODELIS V. The fibrinolytic enzyme system in normal, hemorrhagic and disease states. J Clin Invest. 1958 Jul;37(7):965–973. doi: 10.1172/JCI103692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., PRITCHARD J. A., COLOPY J. E. Hemorrhagic states during pregnancy. N Engl J Med. 1955 Jul 14;253(2):63–contd. doi: 10.1056/NEJM195507142530206. [DOI] [PubMed] [Google Scholar]
- ROSENBERG A. A. Plasma fibrinogen determination; a rapid titration method. Clin Chem. 1956 Oct;2(5):331–333. [PubMed] [Google Scholar]
- SCOTT E. V., MATTHEWS W. F., BUTTERWORTH C. E., Jr, FROMMEYER W. B., Jr Abnormal plasma proteolytic activity; diagnosis and treatment. Surg Gynecol Obstet. 1954 Dec;99(6):679–688. [PubMed] [Google Scholar]